Tristel PLC

LSE TSTL.L

Tristel PLC Debt to Equity Ratio for the year ending June 30, 2024: 0.18

Tristel PLC Debt to Equity Ratio is 0.18 for the year ending June 30, 2024, a 7.15% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Tristel PLC Debt to Equity Ratio for the year ending June 30, 2023 was 0.17, a -15.79% change year over year.
Tristel PLC Debt to Equity Ratio for the year ending June 30, 2022 was 0.20, a 2.13% change year over year.
Tristel PLC Debt to Equity Ratio for the year ending June 30, 2021 was 0.20, a -6.92% change year over year.
Tristel PLC Debt to Equity Ratio for the year ending June 30, 2020 was 0.21, a 0.00% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

LSE: TSTL.L

Tristel PLC

CEO	Mr. Matthew G. Sassone
IPO Date	June 1, 2005
Location	United Kingdom
Headquarters	Lynx Business Park
Employees	250
Sector	Health Care
Industries Pharmaceuticals

Description

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Key trends

Past 5 years